Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MorphoTEP With FDG in Severe Sepsis of Unspecified Etiology
NCT00791310Phase 3Unknown
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Nov 2008
- Primary completion
- Oct 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fludeoxyglucose f 18 in sepsis, sponsored by CHRU de Nancy - Hôpital Central. Status: unknown.
02
Drugs
fludeoxyglucose f 18
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00791310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00791310.